Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials - Quiz - MDSpire

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials

  • By

  • Artem Oganesyan

  • Andrew Gregory

  • Mark Gregory

  • Deivid Badalian

  • Asatur Chakmanyan

  • Lusine Harutyunyan

  • Vahe Khachatryan

  • Abhay Aradhya

  • Aheed Javaid

  • Yervand Hakobyan

  • Christian J Fidler

  • Pierluigi Porcu

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials

  • by Artem Oganesyan, Andrew Gregory, Mark Gregory, Deivid Badalian, Asatur Chakmanyan, Lusine Harutyunyan, Vahe Khachatryan, Abhay Aradhya, Aheed Javaid, Yervand Hakobyan, Christian J Fidler, Pierluigi Porcu

  • June 26, 2026

Related Content

Immune niche-associated and niche-regulated plasticity in glioblastoma: state transitions, immune escape, and therapeutic vulnerabilities

Clinical and prognostic implications of pituitary tumor-transforming gene 1 in solid tumors

MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance